Human papillomavirus (HPV) infection

The program envisions immunization of women and men under 45 years of age with the human papillomavirus vaccine.

The vaccine reduces the risk of developing cervical cancer by 90%, the cost of which is fully covered by state funding.

Immunization is available to:

• Citizens of Georgia, persons permanently residing in Georgia, and the population living in occupied territories;
• Persons under 18 years of age who are legally present on the territory of Georgia for more than 3 months and are subject to routine vaccination according to the National Immunization Calendar.